Lateral‑flow immunoassays and handheld blood‑glucose monitors remain dominant due to simplicity, speed, and widespread use in home and clinical scenarios https://www.einpresswire.com/article/835010297/point-of-care-diagnostics-market-to-surpass-106b-by-2033-driven-by-rapid-testing-and-decentralized-care